text:  Coronasomnia promoting resilience through insomnia treatment The term coronasomnia is used in popular science to describe sleep disorders associated with the COVID 19 pandemic These disorders may also affect part of the population in the aftermath of the pandemic Early scientific evidence suggests that COVID 19 associated insomnia and insomniac symptoms can become chronic and will continue to preoccupy the sleep medicine community even after the pandemic has ended A literature review was conducted in Medline and Google Scholar using the following combination of keywords insomnia and COVID 19 insomnia and long COVID insomnia PTSD and COVID 19 and fatigue and insomnia in long COVID In addition the authors reviewed several recent articles published by members of the European Insomnia Network Studies on insomnia and COVID 19 show significant associations between acute infection and insomnia in affected individuals The prevalence of insomnia symptoms in COVID 19 affected individuals was 36 to 88 which is significantly higher than the estimated 10 to 40 prevalence of insomnia in the general population Digital therapy as a current treatment option for insomnia can be offered to patients regardless of physical distance Accordingly not only early approval of therapy apps but also person led digital therapy options for insomnia would be recommended The inclusion of personalised and sleep coaching measures in the area of occupational health management is encouraged 